Delphia (USA)’s Repligen RGEN Stock Holding History

Delphia (USA)’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-804	Closed	-$213K	–	388
2021 Q4	$213K	Buy	+804	New	+$217K	0.23%	204

Other funds holding RGEN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Delphia (USA)'s RGEN Position: Q1 2022 in Review

Delphia (USA) sold out of Repligen (RGEN) in Q1 2022, closing a stake of 804 shares — an estimated $213K sold.

Delphia (USA) first reported a position in RGEN in Q4 2021 and held it in 1 quarter. The position peaked at $213K in Q4 2021. 450 funds tracked by Wall St. Rank hold RGEN as of Q1 2022.

Delphia (USA) reported no remaining Repligen position as of Q1 2022 after selling out during the quarter.
Delphia (USA) sold 804 Repligen shares in Q1 2022, an estimated $213K.
Delphia (USA) first reported a position in Repligen in Q4 2021 and held it in 1 quarter.
Delphia (USA)'s Repligen position peaked at $213K in Q4 2021.
450 funds tracked by Wall St. Rank held Repligen as of Q1 2022.

Based on Delphia (USA)'s 13F filing for Q1 2022, filed 16 May 2022.